- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging PEGylated non-biologic drugs
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2019-04-08
DOI
10.1080/14728214.2019.1604684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamers: Uptake mechanisms and intracellular applications
- (2018) Sorah Yoon et al. ADVANCED DRUG DELIVERY REVIEWS
- Battle of GLP-1 delivery technologies
- (2018) Minzhi Yu et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent progress in dendrimer-based nanomedicine development
- (2018) Yejin Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
- (2018) Miloš Erak et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration
- (2017) Rehan M Hussain et al. EXPERT OPINION ON EMERGING DRUGS
- A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer
- (2017) G. Rustin et al. GYNECOLOGIC ONCOLOGY
- Polymer therapeutics and the EPR effect
- (2017) Hiroshi Maeda JOURNAL OF DRUG TARGETING
- NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential
- (2017) Takahiro Miyazaki et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacologic Profile of Naloxegol, a Peripherally Acting µ -Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
- (2017) Eike Floettmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- MP393LONG-TERM SAFETY AND EFFECTIVENESS OF ECULIZUMAB FOR PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: OUTCOMES FROM A PROSPECTIVE OBSERVATIONAL CLINICAL TRIAL
- (2017) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone
- (2017) Lynn Webster et al. PAIN MEDICINE
- Magnetic Resonance and Ultrastructural Characterization of PEGylation-associated Vacuolation in Nonclinical Models
- (2017) Thomas Forest et al. TOXICOLOGIC PATHOLOGY
- The early days of PEG and PEGylation (1970s–1990s)
- (2016) Allan S. Hoffman Acta Biomaterialia
- Characterization of the Reversed-Phase Chromatographic Behavior of PEGylated Peptides Based on the Poly(ethylene glycol) Dispersity
- (2016) Eun Ji Park et al. ANALYTICAL CHEMISTRY
- Improvement of the in vitro safety profile and cytoprotective efficacy of amifostine against chemotherapy by PEGylation strategy
- (2016) Xiao Yang et al. BIOCHEMICAL PHARMACOLOGY
- Trimeric PEG-Conjugated Exendin-4 for the Treatment of Sepsis
- (2016) Wonhwa Lee et al. BIOMACROMOLECULES
- Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
- (2016) M Boyce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice
- (2016) Sander A Huisman et al. BRITISH JOURNAL OF PHARMACOLOGY
- Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications
- (2016) Anisha A. D’souza et al. Expert Opinion on Drug Delivery
- Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
- (2016) Terhi Hermanson et al. Expert Opinion On Drug Safety
- Etirinotecan pegol for the treatment of breast cancer
- (2016) Elena López-Miranda et al. EXPERT OPINION ON PHARMACOTHERAPY
- Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015)
- (2016) Eun Ji Park et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Drug and protein delivery by polymer conjugation
- (2016) Antonella Grigoletto et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
- (2016) A Michael Lincoff et al. LANCET
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
- (2016) Christian Lubich et al. PHARMACEUTICAL RESEARCH
- Site-selective enzymatic chemistry for polymer conjugation to protein lysine residues: PEGylation of G-CSF at lysine-41
- (2016) A. Mero et al. Polymer Chemistry
- Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
- (2015) Yeh-Hsing Lao et al. ACS Nano
- PEGylated lysozymes with anti-septic effects in human endothelial cells and in mice
- (2015) Wonhwa Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Releasable Conjugation of Polymers to Proteins
- (2015) Yuhui Gong et al. BIOCONJUGATE CHEMISTRY
- Synthesis and characterization of monodisperse poly(ethylene glycol)-conjugated collagen pentapeptides with collagen biosynthesis-stimulating activity
- (2015) Myung Sun Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Naloxegol: A Review of Its Use in Patients with Opioid-Induced Constipation
- (2015) Karly P. Garnock-Jones DRUGS
- What is the future of PEGylated therapies?
- (2015) Magdalena Swierczewska et al. EXPERT OPINION ON EMERGING DRUGS
- Site-Specific PEGylation of Therapeutic Proteins
- (2015) Jonathan Dozier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PEGylated Biopharmaceuticals
- (2015) Inge A. Ivens et al. TOXICOLOGIC PATHOLOGY
- Nonclinical evaluation of the potential for mast cell activation by an erythropoietin analog
- (2015) James L. Weaver et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Enzymatic Formation of PEGylated Oligonucleotides
- (2014) Alice Sosic et al. BIOCONJUGATE CHEMISTRY
- Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)
- (2014) Yun Lim Choi et al. Biomolecules & Therapeutics
- Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models
- (2014) Ute Hoch et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
- (2013) F. Schwoebel et al. BLOOD
- The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- (2013) J. Hoellenriegel et al. BLOOD
- Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
- (2013) Amita Patnaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12
- (2013) A Vater et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer
- (2013) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
- (2013) Ahmad Awada et al. LANCET ONCOLOGY
- Peginesatide in Patients with Anemia Undergoing Hemodialysis
- (2013) Steven Fishbane et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- Action and therapeutic potential of oxyntomodulin
- (2013) Alessandro Pocai Molecular Metabolism
- Targeting von Willebrand factor as a novel anti-platelet therapy; Application of ARC1779, an Anti-vWF aptamer, against thrombotic risk
- (2012) Ok-Nam Bae ARCHIVES OF PHARMACAL RESEARCH
- Site-Specific PEGylated Exendin-4 Modified with a High Molecular Weight Trimeric PEG Reduces Steric Hindrance and Increases Type 2 Antidiabetic Therapeutic Effects
- (2012) Tae Hyung Kim et al. BIOCONJUGATE CHEMISTRY
- A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
- (2012) G. S. Jameson et al. CLINICAL CANCER RESEARCH
- Peginesatide and erythropoietin stimulate similar erythropoietin receptor–mediated signal transduction and gene induction events
- (2012) Jennifer M. Green et al. EXPERIMENTAL HEMATOLOGY
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- Current drug research on PEGylation with small molecular agents
- (2012) Wenjun Li et al. PROGRESS IN POLYMER SCIENCE
- Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age-Related Macular Degeneration
- (2011) Anthony S. Basile et al. JOURNAL OF CLINICAL PHARMACOLOGY
- State of the art in PEGylation: The great versatility achieved after forty years of research
- (2011) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
- (2011) Chiara Clementi et al. MOLECULAR PHARMACEUTICS
- Application of microchip CGE for the analysis of PEG-modified recombinant human granulocyte-colony stimulating factors
- (2010) Eun Ji Park et al. ELECTROPHORESIS
- Relevance of folic acid/polymer ratio in targeted PEG–epirubicin conjugates
- (2010) Fabiana Canal et al. JOURNAL OF CONTROLLED RELEASE
- PEG conjugates in clinical development or use as anticancer agents: An overview
- (2009) Gianfranco Pasut et al. ADVANCED DRUG DELIVERY REVIEWS
- Emerging PEGylated drugs
- (2009) Jung Seok Kang et al. EXPERT OPINION ON EMERGING DRUGS
- Separation of positional isomers of mono-poly(ethylene glycol)-modified octreotides by reversed-phase high-performance liquid chromatography
- (2009) Eun Ji Park et al. JOURNAL OF CHROMATOGRAPHY A
- In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry
- (2009) Kenichi Tanaka et al. THROMBOSIS AND HAEMOSTASIS
- Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
- (2008) Hong Zhao et al. BIOCONJUGATE CHEMISTRY
- Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model
- (2008) P. Sapra et al. CLINICAL CANCER RESEARCH
- Releasable PEGylation of proteins with customized linkers
- (2007) David Filpula et al. ADVANCED DRUG DELIVERY REVIEWS
- Formulation of Neulasta® (pegfilgrastim)
- (2007) Deirdre Murphy Piedmonte et al. ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now